IL6 and COVID-19: A recent series of cytokine-focused prospective studies in critically ill COVID-19 patients found that IL-6 concentrations were significantly higher than previously reported using clinical IL-6 measurements, both in absolute terms and relative to other inflammatory airway conditions like ARDS (67–69).